Toxicological assessment of tridecafluorohexylethyl methacrylate (6:2 FTMAC)

Toxicology

Volumn 292, Issue 1, 2012, Pages 42-52

  Anand, Sathanandam S ^a   Serex, Tessa L ^a   Carpenter, Carol ^a   Donner, E Maria ^a   Hoke, Robert ^a   Buck, Robert C ^a   Loveless, Scott E ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Aquatic toxicity; Fluorotelomer; Genotoxicity; Mammalian toxicity; Tridecafluorohexylethyl methacrylate

Indexed keywords

METHACRYLIC ACID DERIVATIVE; TRIDECAFLUOROHEXYLETHYL METHACRYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MINERALIZATION; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FEMUR; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY MASS; LIVER WEIGHT; MALE; MICRONUCLEUS; MOUSE; NONHUMAN; NUTRITIONAL PARAMETERS; OUTCOME ASSESSMENT; PATHOLOGY; PLASMA; PRIORITY JOURNAL; RAT; SKIN TOXICITY; THYROID WEIGHT; TOOTH; URINE;

ANIMALS; CARCINOGENS; CELLS, CULTURED; CHLOROPHYTA; CLADOCERA; CYPRINIDAE; FEMALE; HUMANS; MALE; METHACRYLATES; MICE; MICE, INBRED CBA; MICE, INBRED ICR; MICRONUCLEUS TESTS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; TOXICITY TESTS;

ANIMALIA; BACTERIA (MICROORGANISMS); DAPHNIA MAGNA; MAMMALIA; PIMEPHALES PROMELAS; RATTUS; SELENASTRUM CAPRICORNUTUM;

EID: 84855316968     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.11.016     Document Type: Article

References (46)

1. Andrew D. PSD Guidance Document: Interpretation of Liver Enlargement in Regulatory Toxicity Studies 2005, York, England, Pesticides Safety Directorate.
2. Butt C.M., Muir D.C.G., Mabury S.A. Biotransformation of the 8:2 fluorotelomer acrylate in rainbow trout. 1. In vivo dietary exposure. Environ. Toxicol. Chem. 2010, 29:2726-2735.
3. Butt C.M., Muir D.C.G., Mabury S.A. Biotransformation of the 8:2 fluorotelomer acrylate in rainbow trout. 2. In vitro incubations with liver and stomach S9 fractions. Environ. Toxicol. Chem. 2010, 29:2736-2741.
4. Cattley R.C., Popp J.A. Liver. Handbook of Toxicologic Pathology 2002, Academic Press, New York, 202 pp. 2nd ed. W.M. Haschek, C.G. Rousseaux, M.A. Wallig (Eds.).
5. Clive D., Spector J.F.S. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutation Res. 1975, 31:17-29.
6. Condie L.W., Laurie R.D., Mills T., Robinson M., Bercz J.P. Effect of gavage vehicle on hepatotoxicity of carbon tetrachloride in CD-1 mice: corn oil versus Tween 60 aqueous emulsion. Fundam. Appl. Toxicol. 1986, 7:199-206.
7. Dearfield K.L., Thybaud V., Cimino M.C., Custer L., Czich A., Harvey J.S., Hester S., Kim J.H., Kirkland D., Levy D.D., Lorge E., Moore M.M., Ouédraogo-Arras G., Schuler M., Suter W., Sweder K., Tarlo K., van Benthem J., van Goethem F., Witt K.L. Follow-up actions from positive results of in vitro genetic toxicity testing. Environ. Mol. Mutagen 2011, 52(3):177-204.
8. Draize J., Woodard G., Calvery H. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharm. Exp. Ther. 1944, 82:377-390.
9. Dunn O.J. Multiple contrasts using rank sums. Technometrics 1964, 6:241-252.
10. Dunnett C.W. Pairwise multiple comparisons in the unequal variance case. J. Amer. Statist. Assoc. 1980, 75:796-800.
11. ECETOC, 2002. Recognition of, and differentiation between, adverse and non-adverse effects in toxicology studies. Technical Report 85, ECETOC, p. 24.
12. Fasano W.J., Carpenter S.C., Gannon S.A., Snow T.A., Stadler J.C., Kennedy G.L., Buck R.C., Korzeniowski S.H., Hinderliter P.M., Kemper R.A. Absorption, distribution, metabolism, and elimination of 8:2 fluorotelomer alcohol in the rat. Tox. Sci. 2006, 91:341-355.
13. Fasano W.J., Sweeney L.M., Mawn M.P., Nabb D.L., Szostek B., Buck R.C., Gargas M.L. Kinetics of 8:2 fluorotelomer alcohol and its metabolites, and liver glutathione status following daily oral dosing for 45 days in male and female rats. Chem. Biol. Interact. 2009, 180:281-295.
14. Fisher R.A. Statistical Methods for Research Workers 1985, Haffner, New York. 13th ed.
15. Greaves P. Liver and pancreas. Histopathology of Preclinical Toxicity Studies-Interpretation and Relevance in Drug Safety Evaluation 2007, 476-477. Elsevier. P. Greaves (Ed.).
16. Johnson S., McKillop D., Miller J., Smith I.K. The effects on rat thyroid function of a hepatic microsomal enzyme inducer. Hum. Exp. Toxicol. 1993, 12:153-158.
17. Kastenbaum M.A., Bowman K.O. Tables for determining the statistical significance of mutation frequencies. Mutation Res. 1970, 9:527-549.
18. Khan K.N.M., Alden C.L. Kidney. Handbook of Toxicologic Pathology 2002, 294-298. Academic Press, New York. 2nd ed. W.M. Haschek, C.G. Rousseaux, M.A. Wallig (Eds.).
19. Kissa E. Fluorinated Surfactants and Repellents. Surfactant Science Series 2001, vol. 97. Marcel Dekker, New York, NY, pp. 1-615.
20. Kruskal W.H., Wallis W.A. Use of ranks in one-criterion analysis of variance. J. Am. Stat. Assoc. 1952, 47:583-621.
21. Ladics G.S., Stadler J.C., Makovec G.T., Everds N.E., Buck R.C. Subchronic toxicity of a fluoroalkylethanol mixture in rats. Drug Chem. Toxicol. 2005, 28:135-158.
22. Ladics G.S., Kennedy G.L., O'Connor J., Everds N., Malley L.A., Frame S.R., Gannon S., Jung R., Roth T., Iwai H., Shin-ya S. 90-day oral gavage toxicity study of 8-2 fluorotelomer alcohol in rats. Drug Chem. Toxicol. 2008, 31:189-216.
23. Latimer K.S., Mahaffey E.A., Prasse K.W. Duncan and Prasse's Veterinary Laboratory Medicine: Clinical Pathology 2003, Blackwell Publishing, pp. 200-201. 4th ed.
24. Levene H. Robust test for equality of variances. Contributions to Probability and Statistics 1960, 278-292. Stanford University Press, Palo Alto. J. Olkin (Ed.).
25. 14C] 6:2 fluorotelomer alcohol in a flow-through soil incubation system. Chemosphere 2010, 80:716-723.
26. Liu J., Wang N., Szostek B., Buck R.C., Panciroli P.K., Folsom P.W., Sulecki L.M., Bellin C.A. 6-2 Fluorotelomer alcohol aerobic biodegradation in soil and mixed bacterial culture. Chemosphere 2010, 78:437-444.
27. Merrill J.C., Morton J.J.P., Soileau S.D. Metals. Principals and Methods of Toxicology 2007, 841-896. Informa Healthcare, New York. A.W. Hayes (Ed.).
28. Mylchreest E., Ladics G.S., Munley S.M., Buck R.C., Stadler J.C. Evaluation of the reproductive and developmental toxicity of a fluoroalkylethanol mixture. Drug Chem. Toxicol. 2005, 28:159-175.
29. Mylchreest E., Munley S.M., Kennedy G.L. Evaluation of the developmental toxicity of 8-2 telomer B alcohol. Drug Chem. Toxicol. 2005, 28:315-328.
30. Nabb D.L., Szostek B., Himmelstein M.W., Mawn M.P., Gargas M.L., Sweeney L.M., Stadler J.C., Buck R.C., Fasano W.J. In vitro metabolism of 8-2 fluorotelomer alcohol: interspecies comparisons and metabolic pathway refinement. Toxicol. Sci. 2007, 100:333-344.
31. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
32. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environ. Sci. Technol. 2006, 40:32-44.
33. Rao N.S., Baker B.E. Textile finishes & fluorosurfactants. Organofluorine Chemistry. Principles and Commercial Applications 1994, 321-336. Plenum Press, New York. R.E. Banks, B.E. Smart, J.C. Tatlow (Eds.).
34. Ritter S.K. Fluorochemicals go short. Chemical and Engineering News 2010, 88:12-17.
35. Serex T., Munley S., Carpenter C., Donner M., Hoke R., Buck R., Loveless S. Hazard evaluation of 6-2 fluorotelomer alcohol (6-2 FTOH), 1,1,2,2-tetrahydroperfluorooctanol. Toxicol. off. J.Soc. Toxicol. 2009, 108. Abstract #842.
36. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52:591-611.
37. Snedecor G.W., Cochran W.G. Statistical Methods 1967, The Iowa State University Press, IA, pp. 246-248 and 349-352. 6th ed.
38. U.S.EPA Hepatocellular Hypertrophy, HED Guidance Document #G0201 2002, U.S. EPA Office of Pesticide Program, Health Effects Division.
39. U.S. Environmental Protection Agency (EPA), 2009. Long-Chain Perfluorinated Chemicals (LCPFCs) Action Plan, Washington, D.C. http://www.epa.gov/opptintr/existingchemicals/pubs/actionplans/pfcs.html.
40. U.S. Environmental Protection Agency (EPA), 2006. 2010/2015 PFOA Stewardship Program. EPA-HQ-2003-0012-1071.http://www.epa.gov/opptintr/pfoa/pubs/pfoastewardship.htm.
41. Walton R.E., Eisenmann D.R. Ultrastructural examination of dentine formation in rat incisors following multiple fluoride injections. Arch. Oral Biol. 1975, 20:485-488.
42. Wang N., Szostek B., Buck R.C., Folsom P.W., Sulecki L.M., Capka V., Berti W.R., Gannon J.T. Fluorotelomer alcohol biodegradation-direct evidence that perfluorinated carbon chains breakdown. Environ. Sci. Technol. 2005, 39:7516-7528.
43. Wang N., Szostek B., Folsom P.W., Sulecki L.M., Capka V., Buck R.C., Berti W.R., Gannon J.T. Aerobic biotransformation of 14C-labeled 8-2 telomer b alcohol by activated sludge from a domestic sewage treatment plant. Environ. Sci. Technol. 2005, 39:531-538.
44. Wang N., Szostek B., Buck R.C., Folsom P.W., Sulecki L.M., Gannon J.T. 8:2 fluorotelomer alcohol aerobic soil biodegradation: pathways, metabolites, and metabolite yields. Chemosphere 2009, 75:1089-1096.
45. Wilson N.H., Hardisty J.F., Hayes J.R. Short-term, subchronic and chronic toxicology studies. Principles and Methods of Toxicology 2007, Informa Healthcare, New York, 1233 pp. 5th ed. A.W. Hayes (Ed.).
46. Withey J.R., Collins B.T., Collins P.G. Effects of vehicles on the pharmacokinetics and uptake of four halogenated hydrocarbons from the gastrointestinal tract of the rat. J. Appl. Toxicol. 1983, 3:249-253.